International Workshop on HBV Cure 2016

The International HBV Cure Workshop took place on Wednesday 9 November 2016 in Toronto, Canada.

We welcomed 82 unique participants from 17 different countries at this successful 3rd edition of the International Workshop on Hepatitis B Cure.

The Organizing Committee would like to thank all invited speakers and participants for their contribution to this meeting. 

We would like to thank our supporters Gilead, Assembly Biosciences, Arbutus Biopharma, Arrowhead, Humanity and Health, Medlmumme, Roche, Siemens Healthineers, MSD, Janssen, for making this event possible.

Kind regards,

Chairs 2016

More than 250 million people are chronically infected with hepatitis B (HBV) around the globe. The purpose of the program is to inform the participants about the developments in the possibilities to find a cure for HBV. The meeting will be highly interactive with input from experts out of the arena of basic, translational and clinical HBV research.

The field of HBV treatment is undergoing major changes and is on the verge of a paradigm shift. The many new treatment options that are becoming available are providing great hopes for decreasing the burden of the disease, simplifying treatment and ultimately curing and eradicating HBV infection.

In order to optimize curative treatment for HBV, outstanding speakers from around the globe will share the newest therapeutic options for viral hepatitis and experts will discuss the path forward to cure this deadly disease, leading to liver cirrhosis and liver cancer. Questions on which end points to use in therapeutic trials and how to combine different agents targeting the virus and/or immune system will be extensively discussed.

This workshop also brings together global inter-disciplinary experts to provide a framework for how academia and industry should could collaborate to achieve the goal of curing hepatitis B.